[Skip to Content]

Grants Awarded

Grants Awarded in 2024

  • Yamin Li, Ph.D., Pharmacology, PI 
    Hendricks Pilot Grant
    Novel cationic lipid nanoparticle enabled head and neck cancer vaccine  01/01/2024 - 12/31/2024 

Grants Awarded in 2023

  • David Auerbach, Ph.D., Pharmacology, PI 
    NIH R01 Masonic Medical Research Institute
    From variants to mechanisms for cardiac arrythmias            08/01/2023 - 06/30/2024       
  • Norifumi Urao, Ph.D., Pharmacology PI 
    NIH/NIGMS R01   
    Targeting neutrophil clearance to harness myeloid responses for wound healing   09/01/2023 - 08/31/2025
  • Hong Lu, Ph.D., Pharmacology PI 
    HT9425-23-1-0073   DoD Discover Award
    Novel Drug/receptor codelivery to the liver-lung axis to overcome glucocorticoid resistance and acute respiratory distress syndrome in sepsis          05/01/2023 - 04/30/2025
  • David Auerbach, Ph.D., Pharmacology PI 
    Dravet Syndrome Foundation: Clinical Research Grant
    Genetic Substrates and Physiological Triggers for Autonomic and Cardiac Abnormalities in Dravet Syndrome          01/01/2023 - 12/31/2024
  • David Auerbach, Ph.D., Pharmacology PI (Co-PI's: David Auerbach, Inna Hughes)
    University of Rochester Medical Center CTSI - UNYTE Pilot
    Wearable Multi-System Recordings for Improved Disease Diagnostics      07/31/2023 - 06/30/2024
  • Juntao Luo, M.D., Ph.D., Pharmacology, PI 
    PR221368  DoD  PRMRP/TTD Award
    A multimodal nanotrap to alleviate ARDS in traumatic injuries      07/01/2023 - 06/30/2027
  • David Auerbach, Ph.D., Pharmacology, PI 
    NIH-NINDS R61/R33
    Development of a Genetic Rabbit Model of Kcnh2-Mediated Epilepsy, SUDEP, & Long QT Syndrome Type 2      07/01/2023 - 06/30/2026                                                       

 Grants Awarded in 2022

  • Juntao Luo, M.D., Ph.D., Pharmacology, PI 
    SUNY Research Seed Grant Program
    A novel approach to mitigate perioperative ovarian cancer      12/01/2022-05/30/2024
  • Juntao Luo, M.D., Ph.D., Pharmacology, Co-PI  (PI: Kollisch-Singule, co-PI: Luo)
    NIH/NHLBI 1 R42 HL166050-01A1
    Aerosolized Chemically Modified Tetracycline Nanoformation for the Treatment of ARDS      12/01/2022 - 11/30/2025 
  • Yamin Li, Ph.D., Pharmacology PI 
    Carol M. Baldwin Research Fund
    Lipid nanoparticle formulation optimization for breast cancer vaccine development          12/01/2022 - 11/30/2024
  • Yamin Li, Ph.D., Pharmacology PI 
    R03 NIH
    Development of novel lipid nanoparticles for mRNA delivery      05/15/2022 - 02/28/2024
  • Hong Lu, Ph.D., Pharmacology, PI 
    SUNY - Upstate Research Pilot Program
    Novel drug/mRNA co-delivery to the liver-lung axis to overcome glucocorticoid resistance and multiorgan dysfunction syndrome in sepsis      08/01/2022-07/31/2023
  • Juntao Luo, M.D., Ph.D., Pharmacology, PI 
    SUNY Technology Accelerator Fund
    An Injectable Nanoformulation of CMT-3 for Sepsis and ARDS Treatment      07/01/2022 - 08/31/2023                                                       

 Grants Awarded in 2021

  • Juntao Luo, Ph.D., Pharmacology  PI (PI's:  Juntao Luo, Rinki Agarwal)
    Maureen T. O'Hara TEAL THERE's A CURE and Christine Schoeck Blakely Ovarian Cancer Research Fund
    Establish PDX ovarian cancer models to test novel nanotherapeutics
    1/1/2018 - 12/31/2021
  • David Auerbach, Ph.D., Pharmacology PI
    Cure Epilepsy
    Cardiac and autonomic pathological markers for arrhythmias and sudden unexpected death in epilepsy patients  9/01/2021 - 8/31/2022

Grants Awarded in 2020

  • Juntao Luo, Ph.D., Pharmacology PI
    NY FIRST/Empire State Development Program
    Translational Research for a novel Nanotrap hemoperfusion approach for sepsis treatment.  1/1/2020 - 12/31/2024
  • Juntao Luo, Ph.D., Pharmacology, PI (PI:  Luo, Co-PI:  Cooney)
    SUNY - Upstate Research Pilot Program
    A translational study of a novel nanotrap for sepsis treatment using patient blood samples.
    5/1/2020 - 4/30/2021

Grants Awarded in 2019

  • Hong Lu, Ph.D., Pharmacology PI 
    R21, NIH Natl. Inst. Alcohol Abuse
    Liver specific glucocorticoid action in alcoholic liver disease  5/1/2019 - 4/30/2021                        
  • Ying Huang, M.D., Ph.D., Pharmacology PI
    Institutional Bridge Grant 
    MGL in lung cancer signaling and therapeutics 6/1/2019 - 5/31/2020  
  • David Auerbach, Ph.D., Pharmacology PI 
    American Heart Association Career Development Award
    Mechanisms for Arrhythmias and Seizures in Long QT Syndrome 7/1/2018 - 6/30/2021
  • David Auerbach, Ph.D., Pharmacology PI
    Central New York Foundation
    Multi-System Monitoring to Identify Pathological Markers and Mechanisms for Sudden Unexpected Death in Epilepsy 5/1/2019 - 4/30/2020
  • David Auerbach, Ph.D., Pharmacology PI
    American Epilepsy Society Junior Investigator Award (Kevin's Fellow)
    Altered Neuronal Electrical Fundtion in Long QT Syndrome Type 2 7/1/2018 - 6/30/2019
  • Norifumi Urao, M.D., Ph.D., Pharmacology PI
    NIH/NIDDK R01 
    Impact of hematopoietic stem progenitor cell dysfunction on tissue recovery from ischemic injury in metabolic syndrome 8/21/2017 - 7/31/2022 
  • Hong Lu, Ph.D., Pharmacology PI
    R03, NIH Natl. Cancer Inst.
    Liver specific glucocorticoid action in liver cancer  7/1/2019 - 6/30/2021   
  • Laura Szczesniak, M.D., Ph.D. Student, Pharmacology PI (sponsor:  Wojcikiewicz)
    F30, NIH GM
    Mechanism by which Bok binds to IP3Rs and regulates mitochondrial dynamics 8/3/19 - 8/3/22

Grants Awarded in 2018

  • Juntao Luo, Ph.D., Pharmacology, Co-PI (PI Chan)
    R01, NIH/NHLBI
    Novel anti-HCMV strategies    4/15/2018 - 3/31/2022
  • Juntao Luo, Ph.D. Pharmacology, PI (Luo)
    1 R01 GM130941-01 NIH/NIGMS (PI: Luo, J)
    An innovative hemoperfusion nanotrap for sepsis treatment. 09/20/2018-08/30/2022
  • Ying Huang, M.D., Ph.D., Pharmacology, PI 
    Carol M. Baldwin Breast Cancer Research Fund
    Investigation of RBELIA in human breast cancer 12/1/2018 - 11/30/2020 

Grants Awarded in 2017

  • M. Saeed Sheikh, M.D., Ph.D., Pharmacology, PI
    Higher Education Commission
    The International Research Support Initiative Program, February 2, 2017
  • Richard D. Veenstra, Ph.D., Pharmacology, PI
    Central New York Community Foundation
    Molecular and Ionic Mechanisms for Loperamide Overdose Induced Cardiotoxicity, March 1, 2017
  • Juntao Luo, Ph.D., Pharmacology, PI
    NYS Department of Health
    Structure-Based Nanocarrier Design for Targeted Cabazitaxel Delivery in Advanced Breast Cancer Brain Metastases, January 1, 2017
  • Richard D. Veenstra, Ph.D., Pharmacology, PI
    American Heart Association
    Acetylation and Modulation of the Cardiac L-type Ca2+ Current by HDAC Inhibitors    July 1, 2017 - June 30, 2019
  • Richard J.H. Wojcikiewicz, Ph.D., Pharmacology, PI
    Mechanism of IP3 receptor processing by the ERAD pathway and analysis of the
    IP3 receptor-erlin 1/2 complex-RNF170 axis.    07/01/17-05/31/21
  • Richard J.H. Wojcikiewicz, Ph.D., Pharmacology, PI
    Significance of the novel Bok-IP3 receptor interaction.  08/01/17-04/30/21   
  • M. Saeed Sheikh, M.D., Ph.D., Pharmacology, PI 
    Carol M. Baldwin Breast Cancer Research Fund
    Development of a natural product for breast cancer treatment  12/1/2017 - 11/30/2019